Pharmaniaga Berhad reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was MYR 885.49 million compared to MYR 894.94 million a year ago. Net loss was MYR 49.34 million compared to MYR 13.99 million a year ago. Basic loss per share from continuing operations was MYR 0.0367 compared to MYR 0.0107 a year ago. Diluted loss per share from continuing operations was MYR 0.0367 compared to MYR 0.0107 a year ago.
For the nine months, sales was MYR 2,614.67 million compared to MYR 2,618.22 million a year ago. Net loss was MYR 44.73 million compared to net income of MYR 14.47 million a year ago. Basic loss per share from continuing operations was MYR 0.0333 compared to basic earnings per share from continuing operations of MYR 0.011 a year ago. Diluted loss per share from continuing operations was MYR 0.0333 compared to diluted earnings per share from continuing operations of MYR 0.011 a year ago.